Viemed Healthcare Inc
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +120.8% | +10.1% | +52.7% | +42.0% | +54.3% | +36.3% | +4.8% | -0.8% | +32.3% | +14.3% | +21.4% | |
| – | +76.3% | -14.9% | +51.8% | +35.8% | +20.4% | +69.6% | +0.3% | -16.0% | -3.5% | +37.8% | -8.3% | |
| – | +92.3% | +37.8% | +17.5% | +104.3% | +28.3% | +132.0% | -8.3% | -40.5% | -24.1% | +36.6% | -23.0% | |
| – | +92.3% | +37.8% | +17.5% | +104.3% | +28.3% | +132.0% | -8.3% | -40.5% | -24.1% | +36.6% | -23.0% | |
| – | +65.0% | -40.4% | +104.1% | -9.6% | +30.5% | +7.3% | +18.9% | +4.7% | +19.8% | +35.0% | +2.7% | |
| – | +94.5% | +7.3% | -0.3% | +76.8% | -52.9% | +69.9% | +6.4% | +45.5% | +29.5% | -6.7% | +16.8% | |
| – | – | +45.6% | +53.5% | +47.7% | +79.2% | +0.5% | +14.1% | +8.9% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | +10.8% | +78.7% | |
| – | – | – | – | – | – | – | – | – | – | +49.6% | +51.5% | |
| – | +526.7% | +9.6% | +18.2% | +51.2% | +84.5% | -20.6% | -25.0% | -13.8% | +105.5% | +6.8% | +63.2% | |
| – | +386.9% | +9.7% | +43.4% | +48.8% | +32.4% | -11.2% | -22.6% | +5.9% | +70.3% | +16.2% | +10.0% | |
| – | +421.3% | +3.8% | +13.5% | -152.5% | – | -48.2% | -57.5% | -74.5% | +305.3% | -36.7% | +80.6% | |
| – | +16.5% | +113.7% | +79.8% | +73.8% | -2.7% | -41.5% | +56.8% | -6.6% | +51.1% | +26.0% | +32.0% | |
| – | – | -100.0% | – | – | – | -24.0% | -25.7% | – | – | -40.2% | +214.6% | |
| – | +38.2% | +10.5% | +84.3% | +47.5% | +24.7% | +86.9% | +16.1% | +2.4% | +17.3% | +15.4% | +7.7% | |
| – | +38.5% | +10.6% | +63.8% | +40.9% | +15.4% | +92.4% | +11.7% | -4.8% | +13.8% | +12.8% | +14.7% | |
| – | +0.0% | +531.8% | +0.2% | +4.5% | +0.2% | +2.0% | +0.4% | -2.1% | +1.4% | +1.1% | +0.0% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.